drugset / Trial / NCT00419926
Evaluation of the Therapeutic Benefit of an Initial Intensified Dosing Regimen of Mycophenolate Sodium Versus a Standard Regimen in Renal Transplant Patients
RandomizedParallel-groupOpen-labelPrevention
Summary
The purpose of this study is to determine if an initial intensified enteric-coated mycophenolate sodium (Myfortic) dosing regimen administered during the first six weeks post renal transplantation provides improved efficacy, with a similar safety profile, compared to a standard regimen of Myfortic.
Timeline
- Start
- 2006-12
- Primary completion
- 2009-06
- Completion
- 2009-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Mycophenolate Sodium | Unknown | 1440 mg | — |
| Background | Cyclosporine | Peptide | 8 mg/kg | — |
| Background | Cyclosporine | Peptide | 10 mg/kg | — |
| Background | Prednisone | Other / unclassified | 5 mg | Oral |
Indications
No indication recorded.